Yahoo Web Search

Search results

  1. Pulse Biosciences pioneers in the research, design and production of our patented Nanosecond Pulsed Field Ablation ™ (nsPFA ™) technology for use in high impact areas of healthcare. We are currently focused on applying our proprietary CellFX ® nsPFA ™ technology within cardiology.

    • Press Releases

      Pulse Biosciences Schedules First Quarter 2024 Financial...

  2. 6 days ago · Pulse Biosciences, CellFX, Nano-Pulse Stimulation, NPS, nsPFA, CellFX nsPFA and the stylized logos are among the trademarks and/or registered trademarks of Pulse Biosciences, Inc. in the United...

  3. 6 days ago · Pulse Biosciences, Inc. (Nasdaq: PLSE) (the “Company” or “Pulse Biosciences”), a company leveraging its novel and proprietary CellFX® Nanosecond Pulse.

  4. Dec 20, 2023 · Pulse Biosciences, CellFX, Nano-Pulse Stimulation, NPS, nsPFA, CellFX nsPFA and the stylized logos are among the trademarks and/or registered trademarks of Pulse Biosciences, Inc. in the...

  5. Jan 2, 2024 · Pulse Biosciences, CellFX, Nano-Pulse Stimulation, NPS, nsPFA, CellFX nsPFA and the stylized logos are among the trademarks and/or registered trademarks of Pulse Biosciences, Inc. in...

  6. About Pulse Biosciences® Pulse Biosciences is a novel bioelectric medicine company committed to health innovation that has the potential to improve the quality of life for patients. The Company’s proprietary CellFX® nsPFA™ technology delivers nanosecond pulses of electrical energy to non-thermally clear cells while sparing adjacent noncellular tissue.

  1. academic.oup.com has been visited by 10K+ users in the past month

    JLB is the first fully Open Access, peer-reviewed legal journal. Discover the benefits of submitting to JLB.

  1. People also search for